NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Wednesday that its third-quarter revenues fell 13 percent, while its net loss rose 6 percent year over year.

The Alameda, Calif.-based molecular diagnostics firm generated revenues of $40 million for the three-month period ended Sept. 26, down from revenues of $45.8 million for the comparable period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.